BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. G-protein-coupled receptor binding, Hepatitis, Endothelial cell, Laryngoscope)
Bookmark Forward

QuickView for Flt4 (gene)


Body Atlas

Most Correlated Tissues

  1. Rectum colon
  2. Placenta
  3. Ascending colon
  4. Natural killer cell of peripheral blood
  5. Sigmoid colon
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Hereditary lymphedema type I
  2. Lymphedema
  3. Fetal growth abnormality
  4. Cytomegalovirus infection
  5. Varicella-zoster virus infection
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Heme
  2. Albuterol
  3. dimethyl fumarate
  4. VEGFA protein, human
  5. EMD 121974
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. PIM3
  2. TMEM203
  3. PIM2
  4. TOX
  5. SMARCC1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Investigation of Targeting Relationship between Micro-Rna-22 and Vegfr3 in Lung Squamous Cell Carcin…
  2. Morphometric image analysis of vascular endothelial growth factor receptor-3 in preeclamptic, HIV in…
  3. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dep…
  4. Lymphangiogenesis is a feature of acute GVHD, and VEGFR-3 inhibition protects against experimental G…
  5. Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelia…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101
  2. Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery
  3. Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular …
  4. Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)
  5. A Phase II Study of Neoadjuvant Pembrolizumab & Lenvatinib for Resectable Stage III Melanoma
Explore Clinical Trials Results
  • Copyright © 2022 Illumina Inc. All rights reserved.